New program eases breastfeeding fears in new moms

NCT ID NCT06857461

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a program called Uriclarity to help new mothers who worry they aren't making enough breast milk. 91 women from three hospitals in Peru took part. The program included a two-hour training session and follow-up support through WhatsApp. Researchers measured how the mothers' worries changed over two weeks. The goal was to see if this simple support could boost breastfeeding confidence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Uriclarity Program (behavioral lactation support with hands-on training and WhatsApp follow-up)
What this could lead to
If it works, this program could give new mothers a simple, low-cost way to feel more confident about their milk supply and support exclusive breastfeeding.
What could go wrong
This is a small, completed trial in Peru, so results may not apply to other settings. The program relies on smartphone access, which not all mothers have.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

91 people

The number who actually took part.

Started

May 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Postpartum women within 24-48 hours after delivery (vaginal or cesarean). * Term neonates (37-41 weeks of gestation). * Exclusive breastfeeding at enrollment. * Maternal education level of at least primary school completed. * Ability to use a smartphone with WhatsApp for follow-up support. Exclusion Criteria: * Maternal conditions that may affect breastfeeding, such as flat or inverted nipples, diabetes, hypertension, or morbid obesity. * Maternal medication with effects on lactation. * Cigarette smoking. * Neonatal conditions impacting breastfeeding, including congenital heart defects, cleft lip/palate, or ankyloglossia. * Use of infant formula, pacifiers, or bottles before enrollment. * Diagnosed maternal or neonatal illness after study enrollment that may interfere with breastfeeding. * Newborns who experienced hypoglycemia, weight loss equal to or greater than 7%, or any condition related to breastfeeding failure during their hospital stay.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perceived insufficient milk supply are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Crianzamor

    Piura, Piura, Peru

  • Hospital de Chulucanas

    Piura, Chulucanas, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.